A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

被引：4

作者：

Grainger, John ^{[1
]}

Bussel, James B. ^{[2
]}

Cooper, Nichola ^{[3
]}

Tarantino, Michael ^{[4
]}

Blanchette, Victor ^{[5
]}

Despotovic, Jenny ^{[6
]}

Maschan, Alexey ^{[7
]}

Carpenter, Nancy ^{[8
]}

Eisen, Melissa ^{[9
]}

Mehta, Bhakti ^{[9
]}

机构：

[1] Univ Manchester, Royal Manchester Childrens Hosp, Dept Haematol, Manchester, Lancs, England

[2] Weill Cornell Med, Dept Pediat, Div Pediat Hematol Oncol, New York, NY USA

[3] Imperial Coll London, Hammersmith Hosp, London, England

[4] Univ Illinois, Coll Med Peoria, Bleeding & Clotting Disorders Inst, Pediat & Med, Peoria, IL USA

[5] Hosp Sick Children, Toronto, ON, Canada

[6] Texas Childrens Hematol Ctr, Houston, TX USA

[7] Fed Res Ctr Pediat Hematol Oncol & Immunol, Dmitry Rogachev, Moscow, Russia

[8] Amgen Ltd, Uxbridge, Middx, England

[9] Amgen Inc, Thousand Oaks, CA USA

来源：

关键词：

D O I：

10.1182/blood.V128.22.869.869

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

869

引用

页数：8